Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

EASD 2019: ONSET 9 delivers positive data for Novo Nordisk’s Fiasp

Diabetic treatment
Positive results were announced, indicating that Fiasp is a promising option for diabetes patients who require mealtime insulin.